AGYS · Agilysys, Inc. · Stock research

Current Thesis

The binary resolved in the bulls' favour and the tape ignored it. Q1 FY2027 (reported 2026-07-27, quarter ended 2026-06-30) put revenue at a record $87.7M, +14.3% against $76.7M a year earlier, with adjusted diluted EPS $0.49 versus the $0.40 consensus, and management lifted FY2027 revenue guidance to $368–373M from $365–370M while taking full-year subscription growth to "at least 32%" from "at least 30%". Needham (Buy, $130) and Piper Sandler (Overweight, $120) both raised targets on 2026-07-28. Yet the 2026-08-07 close of $108.58 sits marginally below the 2026-07-10 pre-print close of $108.98, RSI(14) is 52.3, and the stock remains 23.1% under the $141.12 52-week high printed before the January 2026 de-rate. The narrative leg on offer is the second half of a recovery re-rate — legacy POS licence vendor becoming a PMS-led subscription business — bought after the fundamental proof arrived and after the price already moved 51.7% in three months.

Bullish and bearish views on Agilysys, Inc.

The model's bull view on Agilysys, Inc. (AGYS), in brief: The subscription mix crossed a threshold. The bear view: Q1 subscription growth of 26.1% is below the ≥32% full-year guide. Both cases follow in full.

Bull Case

• The subscription mix crossed a threshold. Q1 FY2027 recurring revenue was a record $57.7M, 65.9% of total net revenue, up from $48.6M and 63.4% a year earlier; subscription grew 26.1% YoY (2026-07-27 release).
• PMS overtook POS in subscription revenue for the first time, on PMS-and-related-module subscription growth of 39.7% (Q1 FY2027 earnings-call disclosure, 2026-07-27). That is the pivot the story is priced on, showing up as a line item rather than a roadmap.
• Guidance moved up, not sideways. FY2027 revenue range raised to $368–373M and subscription growth to at least 32%, one quarter into the year (2026-07-27).
• Unit economics improved with the mix. Gross margin 63.5% vs 61.7% prior year; adjusted EBITDA $18.3M at 20.8% margin; GAAP net income $9.0M, GAAP diluted EPS $0.32; cash and equivalents $123.7M (Q1 FY2027 release).
• Eighteenth consecutive record revenue quarter, extending the streak that ran through FY2026's $319.3M (+15.9% YoY) and $137.1M subscription (+30.2%) reported 2026-05-18.
• Both post-print target revisions went up, to $130 (Needham) and $120 (Piper Sandler) on 2026-07-28, each above the 2026-08-07 close.

Bear Case

• Q1 subscription growth of 26.1% is below the ≥32% full-year guide. MEASURED: 26.1% in Q1 FY2027 versus +30.2% for all of FY2026. INFERRED: the guide requires acceleration through the remaining three quarters, which puts the burden on the back half rather than on the quarter just banked.
• The lumpy line is still there. Product revenue was $10.3M and professional services a record $19.6M in Q1 FY2027 — the one-time and services components that broke the stock on 2026-01-21, when Q3 FY2025 revenue came in at $69.6M against $73.1M expected alongside a guidance cut and shares fell roughly 25% intraday.
• Record results have not restored the multiple. Price is 23.1% below the $141.12 52-week high; the pre-January-2026 valuation has not been reclaimed despite three consecutive record quarters since.
• Insider supply arrived immediately after the beat. A Form 144 covering 66,205 shares with an aggregate market value of $7,257,802.34 was filed for sale on or after 2026-08-05 via Fidelity on NASDAQ, sourced from restricted-stock vesting (11,309 shares acquired 03/10/2025; 4,970 acquired 05/21/2025) and stock appreciation rights (49,926 acquired 05/28/2024), against 28,205,788 shares outstanding. Further Form 144s dated 2026-08-06 and 2026-08-07 and Form 4s dated 2026-08-07 follow it.
• Cash generation is seasonally thin. Q1 FY2027 free cash flow was $7.3M; FY2026 free cash flow was $68.1M for the full year (2026-05-18). A reader underwriting FCF has one weak quarter and no interim guide.
• Adjusted carries the story. Q1 FY2027 adjusted diluted EPS $0.49 against GAAP $0.32 — the beat headline is the adjusted figure.

Setup & Price Structure

• Last completed daily close $108.58 (2026-08-07). Three-month return +51.7%; distance from the $141.12 52-week high −23.1%; RSI(14) 52.3.
• The four weeks spanning the print produced no net price progress: $108.98 on 2026-07-10, $108.58 on 2026-08-07, with a beat, a raise and two target increases in between. Momentum has decayed while price held — RSI back to the middle of its range from an extended July run that began near $92.31 (2026-06-23).
• The July launch pad near $92 and the round $100 level are the two structures the leg is standing on; $120 and $130 are where the post-print sell-side targets sit above it. The $141.12 high remains the unreclaimed reference from before the January 2026 de-rate.
• Life-cycle: MATURING. Dated by the sequence — fundamentals still improving (2026-07-27 beat-and-raise, 18th record quarter) and sell-side skew still all-constructive (2026-07-28 target hikes), but the flow that carried +51.7% in three months did not extend on the best available news. That is a known story still working, absorbing good headlines rather than repricing on them. Not SATURATED: there is no mainstream-retail coverage cluster and the structure is intact, holding within a dollar of the pre-print close.
• Crowding and positioning observables: compensation-derived insider selling filed into the post-print level (2026-08-05 through 2026-08-07); a target sheet with no visible bear; no earnings date inside the next 30 days, which removes the pre-print gate that shaped the July setup; 28,205,788 shares outstanding, so single-holder liquidations are not trivial relative to float.

Catalyst Calendar (next 30 days)

• 2026-09-02 — 2026 Annual Meeting of Stockholders, 5:00pm ET, held virtually (per DEF 14A filed 2026-07-16). Procedural: votes on directors, auditor and say-on-pay. It is the only scheduled corporate date inside the window and is unlikely to reprice the thesis.
• ~2026-10-26 (est.) — Q2 FY2027 print. Outside the 30-day window. Prior-year cadence: Q1 FY2027 on 2026-07-27, Q3 FY2025 on 2026-01-21. This is the next test of whether subscription growth accelerates off 26.1% toward the ≥32% full-year guide.

Elapsed catalysts

• 2026-08-08 onward — further insider Form 4 / Form 144 filings. Sales already noticed for on-or-after 2026-08-05, with additional Form 144s dated 2026-08-06 and 2026-08-07; whether that supply continues is observable in real time on EDGAR. (passed 1d ago)

What Would Change Our Mind

The leg's foundation is the July breakout that started near $92.31 (2026-06-23) and stalled at $108.98 (2026-07-10) — the beat-and-raise added nothing above it, so the base beneath is the only thing carrying the move. A daily close below $100 gives that shelf back and turns the July run into a completed round trip; a weekly close below $92 ends the recovery leg outright and puts the January 2026 de-rate structure back in charge. On fundamentals, the specific datapoint that would flip the read is subscription growth printing below the 26.1% Q1 rate at the ~2026-10-26 Q2 report, or the FY2027 subscription guide coming back toward ≥30%, which would mark the ≥32% raise as an early-year stretch. The reverse case: a weekly close above $120 with the Q2 print holding subscription above the guide path would re-date the leg as ACCELERATING rather than maturing.

Correlation Notes

• Hospitality capex, not enterprise IT budgets, is the demand cycle. Bookings depend on hotel, casino and resort operators funding PMS/POS replacement; the read-across is US RevPAR trends and resort capex commentary from large operators, and the multi-year Marriott PMS rollout is explicitly back-end loaded, so quarterly cadence is uneven by design.
• Beta to small/mid-cap vertical-software multiples. The +51.7% three-month move ran with a broader recovery in high-multiple software; a de-rate in that complex compresses AGYS without any change in bookings. Watch TOAST and PAR Technology prints as sector-sentiment inputs rather than direct comps.
• The AI framing is a feature layer, not infrastructure exposure. Revenue Intelligence and the Central Reservation System are beta-stage modules guided to "later FY2027"; correlation to AI-infrastructure names is sentiment-driven and can reverse without touching the subscription line.
• Idiosyncratic earnings gaps dominate. The 2026-01-21 −25% intraday move on a $69.6M-vs-$73.1M revenue miss shows print-day dispersion swamping index correlation for this name.